Literature DB >> 6981669

Cyclosporin receptors on human lymphocytes.

B Ryffel, U Götz, B Heuberger.   

Abstract

Utilizing (3H) cyclosporin C (3H CS-C), a dihydroderivative of cyclosporin A (CS-A), an assay for cyclosporin receptors on human peripheral blood lymphocytes was developed. The specific binding of (3H) CS-C was saturable, time-dependent, and reversible. A Kd of 1.2 x 10(-7) M and a maximum binding capacity (Bmax) of 7 pmol/10(6) cells was calculated from equilibrium binding studies. A Scatchard analysis confirmed a single population of high affinity binding sites and about 7 x 10(5) sites/cell. Kinetic analysis of specific binding at 37 degrees C yielded a pseudo-first order rate association constant of 1.1 x 10(6) M-1 min-1 and a zero order dissociation rate constant of 0.19 min-1. The Kd 1.7 x 10(-7) M calculated from kinetic studies agreed well with the value of 1.2 x 10(-7) M determined in equilibrium binding studies. Regarding the specificity of binding, (3H) CS-C binding to lymphocytes was inhibited with CS-A and CS-C; however, no inhibition with the biologically inert keto-CS-A was observed. Mitogens and various growth factors did not compete for the binding site when added simultaneously with the radiolabel. However, pretreatment with T cell mitogens such as PHA, Con A, or the OKT3 antibody reduced (3H) CS-C binding significantly. These results suggest that the binding site for CS-A is closely associated with the mitogenic receptor on lymphocytes.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6981669

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  Analysis of proliferating lymphocyte subpopulations in newborns and adults.

Authors:  H Schneider
Journal:  Eur J Pediatr       Date:  1985-07       Impact factor: 3.183

Review 2.  The influence of cyclosporin A on cell-mediated immunity.

Authors:  A W Thomson; L M Webster
Journal:  Clin Exp Immunol       Date:  1988-03       Impact factor: 4.330

3.  Characterization of cyclosporine A uptake in human erythrocytes.

Authors:  C Reichel; M von Falkenhausen; D Brockmeier; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 4.  Antibody-targeted polymer-bound drugs.

Authors:  B Ríhová
Journal:  Folia Microbiol (Praha)       Date:  1995       Impact factor: 2.099

5.  Cyclosporine does not inhibit mitogen-induced inositol phospholipid degradation in mouse lymphocytes.

Authors:  M K Bijsterbosch; G G Klaus
Journal:  Immunology       Date:  1985-11       Impact factor: 7.397

Review 6.  Regulation of lymphocyte growth by antagonists of interleukin-2 or its cellular receptor.

Authors:  G N Gaulton; J F Markmann
Journal:  Immunol Res       Date:  1988       Impact factor: 2.829

7.  Physical characterization of cyclosporine binding sites in lymphocytes.

Authors:  C D Niebylski; H R Petty
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

8.  Effects of cyclosporin A on humoral immunity to ticks and on cutaneous immediate and delayed hypersensitivity reactions to Ixodes ricinus L. salivary-gland antigens in re-infested rabbits.

Authors:  P Girardin; M Brossard
Journal:  Parasitol Res       Date:  1989       Impact factor: 2.289

9.  Effects of cyclosporine A on biomembranes. Vibrational spectroscopic, calorimetric and hemolysis studies.

Authors:  T J O'Leary; P D Ross; M R Lieber; I W Levin
Journal:  Biophys J       Date:  1986-04       Impact factor: 4.033

10.  Effects of cyclosporin A on expression of IL-2 and IL-2 receptors in normal and multiple sclerosis patients.

Authors:  V L Calder; A S Bellamy; S Owen; C Lewis; P Rudge; A N Davison; M Feldmann
Journal:  Clin Exp Immunol       Date:  1987-12       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.